News

Read time: 0 mins
Compléments Alimentaires
12/05/2021 —
News

Beware of overconsumption of herbal supplements containing coumarin

ANSES recently assessed the risks associated with the coumarin content of certain plants when consumed in food supplements in particular. Coumarin is a natural aromatic compound found in certain plants such as cinnamon. It is used in food as a spice or natural flavouring ingredient. Coumarin can cause liver damage when taken in high doses. To avoid exceeding the tolerable daily intake (TDI) set by EFSA, the Agency recommends keeping coumarin intake through food supplements below 4.8 mg per day for a 60 kg adult. It also advises people with a history of liver disease to avoid consumption of cinnamon-rich foods and food supplements containing coumarin.
Glyphosate Truite
07/05/2021 —
News

Consequences of acute exposure to glyphosate in trout

Research conducted by ANSES shows that exposure to a high concentration of glyphosate does not reduce trout resistance to viral infections. However, the combination of these two stress factors of chemical and infectious origin revealed changes in the activity of some enzymes of energy metabolism in the fish.
Dioxyde Titane
07/05/2021 —
News

Titanium dioxide: news of EFSA's updated assessment of the food additive E171

ANSES notes the conclusions of EFSA's re-assessment of titanium dioxide used as a food additive (E171), which confirm the health concerns raised by the Agency in its own 2017 and 2019 assessments. It will now take the data from this new assessment into account in its ongoing work to assess the risks associated with nanoscale food additives and ingredients. Use of the food additive E171 was suspended in France in January 2020.
Tiques
05/05/2021 —
News

Watch out for ticks, even in your garden

Especially active in the spring and autumn, ticks are the main vectors of pathogens responsible for infectious diseases in Europe. In particular, they transmit the bacterium that causes Lyme disease in humans. Bites can occur in woods and forests, but also in gardens. A new participatory research programme in Nancy, entitled TIQUoJARDIN, is seeking to gain a better understanding of the risks associated with garden ticks and the pathogens they carry.
03/05/2021 —
Portrait

Women at ANSES - "Collaborative work is crucial for monitoring tick-borne diseases"

Sara Moutailler, director of the BIPAR Joint Research Unit, is medical entomologist specialising in ticks.
Fièvre Q
30/04/2021 —
News

How reliable are the tests for Q fever?

The Animal Q Fever Unit of ANSES’s Sophia-Antipolis Laboratory has just published a study comparing the performance of the three commercially available tests for detecting Q fever in animals. This work will help improve the interpretation of test results to better screen for the disease.
Maladies Animales
30/04/2021 —
News

ANSES, EnvA and INRAE renew two joint research units for animal diseases

ANSES, EnvA and INRAE have renewed their agreement on two joint research units (UMRs): the BIPAR unit (molecular biology and parasitic immunology) and the Virology unit. Both units work on animal diseases and the risk of transmission to humans: the first on parasitic diseases and diseases transmitted by arthropod vectors, the second on viral diseases.
références nutritionnelles
23/04/2021 —
News

Publication of the new dietary reference values for the vitamin and mineral intake of the French population

Acquired mainly through our diet, vitamins and minerals are essential to our health, growth and body functions. ANSES is updating the dietary reference values specifying the vitamin and mineral intake required to meet the nutritional needs of the population, without leading to excess. These values will then become the references used by all professionals in the nutrition and health sector.
5 G
20/04/2021 —
News

5G: no new health risks according to the data available

Population exposure to electromagnetic fields in the radiofrequencies band is changing, driven by technological progress and the emergence of new digital habits. As part of the deployment of 5G, new frequency bands are already being used (3.5 GHz band) or are scheduled for use in the near future (26 GHz band). Following on from its expert appraisals on radiofrequencies and health, and based on the scientific data available to date, ANSES considers that the deployment of 5G in the 3.5 GHz frequency band is unlikely to present new risks to health. For the 26 GHz frequency band, the data currently available are insufficient to conclude whether or not there are health effects. More knowledge is required on the links between exposure and health effects. To this end, ANSES is underlining the need to continue research and – in particular – to monitor changes in population exposure with the increase in the number of base stations and the expansion in network use. On 20 April 2021, the Agency launched a public consultation to collect comments from the scientific community and stakeholders.

Pages